Vera Therapeutics, Inc. · NASDAQ:VERA

T. Rowe Price Associates Inc reported a 6.40% stake in Vera Therapeutics, Inc. (Schedule 13G/A)

Event Mar 31, 2026 · Filed May 15, 2026

T. Rowe Price Associates Inc reported a 6.40% stake in Vera Therapeutics, Inc., 4,573,684 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).

Stake
6.40%
Shares
4,573,684
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
T. Rowe Price Associates, Inc.6.40%4,573,684

Source

View original at SEC

Related